Healthcare / BiotechnologyUpdated 2026-05-10 22:07 UTC

OSL/ONCIN stock hub

OSL/ONCIN has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

OSL/ONCINis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

210.5M

Oslo Børs

Market data

Price

Recent price action with selectable time range.

OSL/ONCINOSL/ONCIN

—

Loading chart…

In the news

Latest news · OSL/ONCIN

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 n/aP50 n/aP75 n/a

Trailing P/En/a

P25 n/aP50 n/aP75 n/a

ROE-121.8

P25 n/aP50 n/aP75 n/a

ROIC-74.5

P25 n/aP50 n/aP75 n/a

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All OSL/ONCIN market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

159

Groups with data

Currency

NOK

Showing 159 of 159 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	Norway
Country code	NO
Employees	44
Employees Change	10%
Employees Change Percent	29.41
Enterprise value	NOK 36.4M
Exchange	Oslo Børs
Financial currency	NOK
First seen	2026-05-10
Industry	Biotechnology
Isin	NO0013251173
Last refreshed	2026-05-10
Market cap	NOK 210.5M
Price	NOK 47
Price currency	NOK
Rev Per Employee	637,931.82x
Sector	Healthcare
Sic	2836
Symbol	osl/ONCIN
Website	https://www.oncoinvent.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-73.67%
EV Earnings	-0.23x
EV/FCF	-0.28x
EV/Sales	1.3x
FCF yield	-61.76%
P/B ratio	1.44x
P/S ratio	7.5x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Gross margin	100%
Gross Profit	NOK 28.1M
Gross Profit Growth	40.37%
Gross Profit Growth Q	100.46%
Gross Profit Growth3 Y	71.34%
Gross Profit Growth5 Y	69.54%
Net Income	NOK -155.1M
Net Income Growth Quarters	8%
Net Income Growth Years	3%
Pretax Margin	-552.46%
Profit Per Employee	NOK -3.5M
ROA	-52.64
Roa5y	-44.11
ROCE	-107.7
ROE	-121.8
Roe5y	-97.98
ROIC	-74.5

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS Growth Quarters	4
EPS Growth Years	3
Revenue Growth	246.4x
Revenue Growth Q	100.46x
Revenue Growth Quarters	2x
Revenue Growth Years	1x
Revenue Growth3 Y	71.34x
Revenue Growth5 Y	35.01x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	NOK 0.15
Assets	NOK 205M
Cash	NOK 177.6M
Current Assets	NOK 187.3M
Current Liabilities	NOK 58M
Debt	NOK 3.6M
Debt Equity	NOK 0.02
Debt FCF	NOK -0.03
Equity	NOK 146.3M
Liabilities	NOK 58.6M
Long Term Assets	NOK 17.6M
Long Term Liabilities	NOK 675,000
Net Cash	NOK 174.1M
Net Cash By Market Cap	NOK 82.69
Net Cash Growth	37.9%
Net Debt Equity	NOK -1.19
Tangible Book Value	NOK 146.3M
Tangible Book Value Per Share	NOK 0.33

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	3.23
Net Working Capital	NOK -45.4M
Quick ratio	3.2
Working Capital	NOK 129.4M
Working Capital Turnover	NOK 0.26

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-395.91%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
50-day SMA	46.35
All Time High	134.8
All Time High Change	-65.13%
All Time High Date	2025-11-06
All Time Low	40.1
All Time Low Change	17.21%
All Time Low Date	2026-03-03
ATR	2.07
Beta1y	-0.1
Ch YTD	-4.28
High	47
High52	134.8
High52 Date	2025-11-06
High52ch	-65.13%
Low	45.1
Low52	40.1
Low52 Date	2026-03-03
Low52ch	17.21%
Ma50ch	1.41%
RSI	46.9
RSI Monthly	0
RSI Weekly	22.02
Sharpe ratio	-0.9x
Sortino ratio	-1.27
Total Return	-395.91%
Tr YTD	-4.28
Tr1m	1.75%
Tr1w	-2.08%
Tr3m	9.21%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	NOK -158.3M
Operating margin	-564.1

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	2,998,256%
Net Borrowing	-2,523,000
Shares Insiders	1.27%
Shares Out	4,478,412
Shares Qo Q	25,157.21%
Shares Yo Y	395.91%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	NOK -133.9M
Average Volume	5,640.2x
Bv Per Share	0.33
CAPEX	NOK -119,000
Ch1m	1.75
Ch1w	-2.08
Ch3m	9.21
Ch6m	-61.29
Change	1.29%
Change From Open	4.21
Close	46.4
Days Gap	-2.8
Depreciation Amortization	8,535,000
Dollar Volume	84,553
Earnings Date	2026-04-22
EBIT	NOK -158.3M
EBITDA	NOK -149.8M
EPS	NOK -1.25
F Score	2
FCF	NOK -130M
FCF EV Yield	-356.81x
FCF Per Share	NOK -29.03
Financing CF	119,210,000
Fiscal Year End	December
Investing CF	3,366,000
Is Primary Listing	1
Last Earnings Date	2026-04-22
Last Report Date	2025-12-31
Last Split Date	2026-01-19
Last Split Type	Reverse
Ma20	48.61
Ma20ch	-3.31%
Net CF	43,975,000
Next Earnings Date	2026-08-27
Open	45.1
Position In Range	100
Ppne	15,581,000
Price Date	2026-05-08
Ptbv Ratio	1.44
Relative Volume	0.32x
Revenue	28,069,000x
SBC By Revenue	13.8x
Share Based Comp	3,873,000
Tr6m	-39.59%
Volume	1,799
Z Score	-0.78

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does OSL/ONCIN pay a dividend?

Capital-return profile for this ticker.

Ownership

Who owns OSL/ONCIN?

Insider, institutional, and short-interest positioning.

Institutional ownership

n/a

Share of float held by funds and institutions

Insider ownership

+1.3%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

+395.9%

Negative means the company is buying back shares.

Technical

OSL/ONCIN momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

46.9

Neutral momentum band

Price vs 200-day MA

n/a

50/200-day relationship not available

Beta (5Y)

n/a

Sensitivity to the broader market

Sharpe ratio

-0.90

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About OSL/ONCIN

Hub-level FAQ points readers to the deeper analysis pages.

What is the current osl/ONCIN stock rating?

osl/ONCIN is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full osl/ONCIN analysis?

The full report lives at /stocks/osl/ONCIN/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for osl/ONCIN?

The latest report frames osl/ONCIN around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the osl/ONCIN page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.